Ardelyx, Inc. provided earnings guidance for the full year 2023. For the year, the company expects U.S. net product revenue for IBSRELA to be between $76.0 and $78.0 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.745 USD | +1.73% | -4.21% | +10.16% |
May. 24 | Ardelyx Shares Fall; Chief Commercial Officer Resigns | MT |
May. 23 | Ardelyx, Inc. Announces Rodriguez Would Resign as Chief Commercial Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.16% | 1.55B | |
+17.40% | 124B | |
+15.73% | 109B | |
-6.92% | 23.84B | |
+1.98% | 22.42B | |
-14.29% | 17.5B | |
-7.73% | 16.61B | |
-37.63% | 16.43B | |
+2.51% | 13.4B | |
+25.56% | 11.47B |
- Stock Market
- Equities
- ARDX Stock
- News Ardelyx, Inc.
- Ardelyx, Inc. Provides Earnings Guidance for the Full Year 2023